Rho kinase inhibitor BA-1049 (R) and active metabolites thereof

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11198680
APP PUB NO 20200199105A1
SERIAL NO

16735359

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

BA-1049 (R) and its active metabolite are disclosed. Also disclosed are pharmaceutical formulations containing BA-1049 (R) or its active metabolite.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

  • BIOAXONE BIOSCIENCES, INC.

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Abbinanti, Matthew D Westford, US 6 25
Bond, Moritz Lisa Burtonsville, US 7 21
McKerracher, Lisa Boston, US 32 371
Rosen, Kenneth M Milton, US 14 173
Ruschel, Joerg Cambridge, US 7 25

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Jun 14, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Jun 14, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jun 14, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00